Gilead Sciences (GILD) Q1 2012 Earnings Call April 26, 2012 5:00 pm ET Executives Susan Hubbard - Vice President of Investor Relations Robin L. Washington - Chief Financial Officer, Principal Accounting Officer and Senior Vice President Kevin B. Young - Executive Vice President of Commercial Operations Norbert W. Bischofberger - Chief Scientific Officer and Executive Vice President of Research & Development John F. Milligan - President and Chief Operating Officer Analysts Geoffrey C. Meacham - JP Morgan Chase & Co, Research Division Mark J. Schoenebaum - ISI Group Inc., Research Division Rachel L. McMinn - BofA Merrill Lynch, Research Division Matthew Roden - UBS Investment Bank, Research Division Yaron Werber - Citigroup Inc, Research Division Sapna Srivastava - Goldman Sachs Group Inc., Research Division Robyn Karnauskas - Deutsche Bank AG, Research Division Thomas Wei - Jefferies & Company, Inc., Research Division Michael J. Yee - RBC Capital Markets, LLC, Research Division Lee Kalowski - Crédit Suisse AG, Research Division Christine Chiou - Barclays Capital, Research Division Brian Skorney - Brean Murray, Carret & Co., LLC, Research Division Philip Nadeau - Cowen and Company, LLC, Research Division PresentationOperator
Ladies and gentlemen, thank you for standing by, and welcome to Gilead Sciences First Quarter 2012 Earnings Conference Call. My name is Stacy, and I will be your conference operator for today. [Operator Instructions] As a reminder, this conference call is being recorded today, April 26, 2012. I would now like to turn the call over to Susan Hubbard, Vice President of Investor Relations. Please go ahead. Susan Hubbard Thank you, Stacy, and good afternoon, everyone. Welcome to Gilead's First Quarter 2012 Earnings Conference Call. We issued a press release this afternoon providing earnings results for the quarter. This press release is available on our website as are the slides to provide more detail around some of the topics we will cover on today's call.